|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Columbia University |
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000200 |
The purpose of this study is to compare the effects of buprenorphine or methadone maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving, in opiate-dependent cocaine users.
Condition | Intervention | Phase |
Cocaine-Related Disorders |
Drug: Methadone |
Phase II |
Drug Information available for: | Methadone Methadone hydrochloride 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver), Active Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Cocaine Effects in Humans: Physiology and Behavior |
Enrollment: | 19 |
Study Start Date: | January 1997 |
Study Completion Date: | January 1998 |
Primary Completion Date: | January 1998 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
United States, New York | |||||
Columbia University | |||||
New York, New York, United States, 10023 |
National Institute on Drug Abuse (NIDA) |
Columbia University |
Principal Investigator: | Marian Fischman, Ph.D. | Columbia University |
Study ID Numbers: | NIDA-03818-1, R01-03818-1 |
First Received: | September 20, 1999 |
Last Updated: | September 10, 2008 |
ClinicalTrials.gov Identifier: | NCT00000200 |
Health Authority: | United States: Federal Government; United States: Food and Drug Administration |
|
|